Clinical Trial Update: Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia [NA]

View source ↗

Summary

This clinical trial evaluating Plasma Rich in Growth Factors (PRGF-Endoret) for androgenetic alopecia was withdrawn before completion, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Plasma Rich in Growth Factors (PRGF-Endoret)

Snippet

Sponsor: Biotechnology Institute IMASD | Conditions: Androgenetic Alopecia | NA | Status: WITHDRAWN